TerrAscend (TSNDF) Cash & Current Investments (2021 - 2026)

TerrAscend's (TSNDF) quarterly Cash & Current Investments came in at $472000.0 in Q1 2026, down 98.44% year-on-year from $30.2 million in Q1 2025, and little changed on a QoQ basis from $472000.0 in Q4 2025.

TerrAscend (TSNDF) Cash & Current Investments (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Cash & Current Investments data on file, last reported at $472000.0 in Q1 2026.

  • On a quarterly basis, Cash & Current Investments fell 98.44% year-over-year to $472000.0 in Q1 2026; TTM through Mar 2026 was $472000.0, a 98.44% decrease from a year earlier, with the FY2025 full-year figure at $472000.0, down 79.77% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $472000.0, roughly flat from $472000.0 in the prior quarter.
  • Over the last five years, Cash & Current Investments for TSNDF reached as high as $92.5 million in Q1 2022 and fell as low as $472000.0 in Q4 2025.
  • Historically, Cash & Current Investments has averaged $21.3 million across 5 years, with a median of $24.2 million in 2023.
  • Across the five-year window, Cash & Current Investments soared 1025.13% in 2024 and slumped 98.44% in 2026, its largest moves.
  • Year by year, Cash & Current Investments stood at $29.8 million in 2022, then slipped by 18.82% to $24.2 million in 2023, then plunged by 90.34% to $2.3 million in 2024, then sank by 79.77% to $472000.0 in 2025, then changed by 0.0% to $472000.0 in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $472000.0 in Q1 2026, $472000.0 in Q4 2025, and $37.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 428.00 Mn
10 TerrAscend 164.05 Mn 163.57 Mn 34.60 Mn 472,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 472,000.00
Dec 31, 2025 472,000.00
Sep 30, 2025 37.51 Mn
Jun 30, 2025 27.66 Mn
Mar 31, 2025 30.23 Mn
Dec 31, 2024 2.33 Mn
Sep 30, 2024 28.39 Mn
Jun 30, 2024 4.85 Mn
Mar 31, 2024 5.08 Mn
Dec 31, 2023 24.15 Mn
Sep 30, 2023 2.52 Mn
Jun 30, 2023 30.85 Mn
Mar 31, 2023 2.63 Mn
Dec 31, 2022 29.75 Mn
Sep 30, 2022 37.84 Mn
Jun 30, 2022 4.68 Mn
Mar 31, 2022 92.53 Mn
Dec 31, 2021 79.64 Mn